Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis

Bertrand Coste, Gunnar Houge, Michael F Murray, Nathan Stitziel, Michael Bandell, Monica A Giovanni, Anthony Philippakis, Alexander Hoischen, Gunnar Riemer, Unni Steen, Vidar Martin Steen, Jayanti Mathur, James Cox, Matthew Lebo, Heidi Rehm, Scott T Weiss, John N Wood, Richard L Maas, Shamil R Sunyaev, Ardem Patapoutian, Bertrand Coste, Gunnar Houge, Michael F Murray, Nathan Stitziel, Michael Bandell, Monica A Giovanni, Anthony Philippakis, Alexander Hoischen, Gunnar Riemer, Unni Steen, Vidar Martin Steen, Jayanti Mathur, James Cox, Matthew Lebo, Heidi Rehm, Scott T Weiss, John N Wood, Richard L Maas, Shamil R Sunyaev, Ardem Patapoutian

Abstract

Mechanotransduction, the pathway by which mechanical forces are translated to biological signals, plays important but poorly characterized roles in physiology. PIEZOs are recently identified, widely expressed, mechanically activated ion channels that are hypothesized to play a role in mechanotransduction in mammals. Here, we describe two distinct PIEZO2 mutations in patients with a subtype of Distal Arthrogryposis Type 5 characterized by generalized autosomal dominant contractures with limited eye movements, restrictive lung disease, and variable absence of cruciate knee ligaments. Electrophysiological studies reveal that the two PIEZO2 mutations affect biophysical properties related to channel inactivation: both E2727del and I802F mutations cause the PIEZO2-dependent, mechanically activated currents to recover faster from inactivation, while E2727del also causes a slowing of inactivation. Both types of changes in kinetics result in increased channel activity in response to a given mechanical stimulus, suggesting that Distal Arthrogryposis Type 5 can be caused by gain-of-function mutations in PIEZO2. We further show that overexpression of mutated PIEZO2 cDNAs does not cause constitutive activity or toxicity to cells, indicating that the observed phenotype is likely due to a mechanotransduction defect. Our studies identify a type of channelopathy and link the dysfunction of mechanically activated ion channels to developmental malformations and joint contractures.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Dysmorphic features of DA5 individuals. (A) Infant photographs of individual 2 showing deep-set small eyes with mild ptosis, restricted shoulder abduction, and flexion contractures in the knees. Deep skin dimples can be seen on the shoulder (red circle) and sternum. (B) The DA of individual 2, 3, and 1 (from top to bottom). Note flexion contractures of the interphalangeal joints, increasing in severity from thumb to little finger. (C) Retinal photograph of individual 3 shows pigmented macular striae. This was not found in individual 1. (D) Flow volume loop of individual 3 showing markedly reduced total lung capacity (∼1 L) and restricted flow dynamics during both inspiration and expiration. (E) Hydrophobicity plot of human PIEZO2 showing Kyte–Doolittle hydrophobicity analysis (19-residue window) done with ProtScale program (Expasy). Triangles indicate the position of I802F and E2727del mutations.
Fig. 2.
Fig. 2.
E2727del PIEZO2 channels display slower inactivation kinetics compared with wild type. (A) Representative traces of MA inward currents at –80 mV in cells transfected with the indicated constructs and subjected to a series of mechanical steps in 1 µm increments. (B) Average maximal current amplitude of MA inward currents at –80 mV. The number of cells tested is shown above bars. (C) Averaged current-voltage relationships of MA currents in cells transfected with hPiezo2 (n = 7 cells), I802F (n = 8 cells), or E2727del (n = 8 cells). The insets show representative MA currents evoked at holding potentials ranging from –80 to +80 mV; inset scale bars are 1 nA and 100 ms. (D) Representative traces of MA currents elicited at –80 and +80 mV holding potentials. Traces were normalized to the peak current, and blue, red, and green dashed lines represent fits of inactivation with a monoexponential equation of human PIEZO2, I802F, and E2727del currents, respectively. (E) Time-constant of inactivation (tau) of PIEZO2 (black dots, n = 7 cells), I802F (red dots, n = 8 cells), and E2727del (green dots, n = 8 cells) currents at different holding potentials. Dots and bars represent mean ± SEM. ns, not statistically different; **P < 0.01; ***P < 0.001; Mann–Whitney test.
Fig. 3.
Fig. 3.
E2727del and I802F PIEZO2 channels recover faster from inactivation compared with wild type. (A) Typical recording traces of PIEZO2, I802F, and E2727del MA currents recorded at –80 mV. The protocol depicted on the top consists of two consecutive mechanical stimulation steps separated by increasing delay and aims at testing recovery from inactivation. The traces for each construct represent superimposition of multiple test-control stimulation pairings at different delta-t intervals. The test current traces are each normalized to the peak of control currents. Peak of test currents are fitted with a monoexponential equation. (B) Average of test peak current/control peak current for PIEZO2 (black, n = 8 cells), I802F (red, n = 7 cells), and E2727del (green, n = 7 cells) are fitted with monoexponential equation. (C) Average of time-constant (tau) of recovery from inactivation determined for each individual cell exemplified in A. The number of cells tested is shown above bars. Dots and bars represent mean ± SEM. **P < 0.01; ***P < 0.001; Mann–Whitney test.

References

    1. Altman H, Davidson L. Amyoplasia congenita (arthrogryposis mutiplex congenita) J Pediatr. 1939;15(4):551–557.
    1. Bamshad M, Van Heest AE, Pleasure D. Arthrogryposis: A review and update. J Bone Joint Surg Am. 2009;91(Suppl 4):40–46.
    1. Hall JG. Arthrogryposis multiplex congenita: Etiology, genetics, classification, diagnostic approach, and general aspects. J Pediatr Orthop B. 1997;6(3):159–166.
    1. Bamshad M, Bohnsack JF, Jorde LB, Carey JC. Distal arthrogryposis type 1: Clinical analysis of a large kindred. Am J Med Genet. 1996;65(4):282–285.
    1. Beals RK, Weleber RG. Distal arthrogryposis 5: A dominant syndrome of peripheral contractures and ophthalmoplegia. Am J Med Genet A. 2004;131(1):67–70.
    1. Castori M, et al. Juvenile macular dystrophy and forearm pronation-supination restriction presenting with features of distal arthrogryposis type 5. Am J Med Genet A. 2009;149A(3):482–486.
    1. Hall JG, Reed SD, Greene G. The distal arthrogryposes: Delineation of new entities—review and nosologic discussion. Am J Med Genet. 1982;11(2):185–239.
    1. Schrander-Stumpel CT, et al. Arthrogryposis, ophthalmoplegia, and retinopathy: Confirmation of a new type of arthrogryposis. J Med Genet. 1993;30(1):78–80.
    1. Williams MS, Elliott CG, Bamshad MJ. Pulmonary disease is a component of distal arthrogryposis type 5. Am J Med Genet A. 2007;143(7):752–756.
    1. Dieterich K, et al. The neuronal endopeptidase ECEL1 is associated with a distinct form of recessive distal arthrogryposis. Hum Mol Genet. 2012 10.1093/hmg/dds514.
    1. McMillin MJ, et al. the University of Washington Center for Mendelian Genomics Mutations in ECEL1 Cause Distal Arthrogryposis Type 5D. Am J Hum Genet. 2013;92(1):150–156.
    1. Gurnett CA, et al. Myosin binding protein C1: A novel gene for autosomal dominant distal arthrogryposis type 1. Hum Mol Genet. 2010;19(7):1165–1173.
    1. Robinson P, et al. Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function. FASEB J. 2007;21(3):896–905.
    1. Sung SS, et al. Mutations in genes encoding fast-twitch contractile proteins cause distal arthrogryposis syndromes. Am J Hum Genet. 2003;72(3):681–690.
    1. Coste B, et al. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science. 2010;330(6000):55–60.
    1. Kim SE, Coste B, Chadha A, Cook B, Patapoutian A. The role of Drosophila Piezo in mechanical nociception. Nature. 2012;483(7388):209–212.
    1. Zarychanski R, et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood. 2012;120(9):1908–1915.
    1. Coste B, et al. Piezo proteins are pore-forming subunits of mechanically activated channels. Nature. 2012;483(7388):176–181.
    1. Dubin AE, et al. Inflammatory signals enhance piezo2-mediated mechanosensitive currents. Cell Rep. 2012;2(3):511–517.
    1. Myers BR, Bohlen CJ, Julius D. A yeast genetic screen reveals a critical role for the pore helix domain in TRP channel gating. Neuron. 2008;58(3):362–373.
    1. Sachs F. Stretch-activated ion channels: What are they? Physiology (Bethesda) 2010;25(1):50–56.
    1. Jaalouk DE, Lammerding J. Mechanotransduction gone awry. Nat Rev Mol Cell Biol. 2009;10(1):63–73.
    1. Nagata K, et al. Damage-induced neuronal endopeptidase is critical for presynaptic formation of neuromuscular junctions. J Neurosci. 2010;30(20):6954–6962.
    1. Schweizer A, et al. Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase family. J Biol Chem. 1999;274(29):20450–20456.
    1. Kwan K, Ross K. Arthrogryposis and congenital absence of the anterior cruciate ligament: a case report. Knee. 2009;16(1):81–82.
    1. Gordon N. Arthrogryposis multiplex congenita. Brain Dev. 1998;20(7):507–511.
    1. Bentley DR, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456(7218):53–59.
    1. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–1760.
    1. DePristo MA. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491–498.
    1. McKenna A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–1303.
    1. McLaren W, et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics. 2010;26(16):2069–2070.
    1. Sherry ST, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–311.
    1. Hoischen A, et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet. 2010;42(6):483–485.
    1. Vissers LE, et al. A de novo paradigm for mental retardation. Nat Genet. 2010;42(12):1109–1112.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir